http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018190542-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82a85d8b540878975fb5ec5f8f53198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4cc7f48e39e2dc974993fb66a2c2c54 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36be77bc5899ec89473462d7667ad1c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44e711c2a66baae06a502a6d57040370 |
| publicationDate | 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2018190542-A1 |
| titleOfInvention | Hypotonic lipolysis composition and preparation method therefor |
| abstract | A hypotonic lipolysis composition and a preparation method therefor are disclosed. That is, the present invention prepares a hypotonic lipolysis composition in which deoxycholic acid, hyaluronidase, and the like are contained in a hypotonic solution comprising distilled water and sodium chloride, thereby: reducing the occurrence, at an injection site, of a consolidation phenomenon caused by using deoxycholic acid alone; reducing adverse effects such as nerve palsy, muscle atrophy, and bone atrophy by reducing influence on cells (for example, including nerve cells, muscle cells, bone cells and the like), excluding adipocytes, and containing fat components, in comparison to the use of deoxycholic acid alone; reducing adverse effects such as edema/swelling, erythema, and pain; increasing adipocyte disruption efficiency according to a combined use of hyaluronidase on the basis of a hypotonic solution; and enabling a medicine for reducing the fat accumulated at a local site to be used through subcutaneous administration. |
| priorityDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.